BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15653667)

  • 1. Radiotargeted gene therapy.
    Buchsbaum DJ; Chaudhuri TR; Zinn KR
    J Nucl Med; 2005 Jan; 46 Suppl 1():179S-86S. PubMed ID: 15653667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and clinical studies of peptide receptor radionuclide therapy.
    Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
    Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidates for peptide receptor radiotherapy today and in the future.
    Reubi JC; Mäcke HR; Krenning EP
    J Nucl Med; 2005 Jan; 46 Suppl 1():67S-75S. PubMed ID: 15653654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs.
    Buchsbaum DJ
    Semin Nucl Med; 2004 Jan; 34(1):32-46. PubMed ID: 14735457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
    Mariani G; Erba PA; Signore A
    J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
    Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
    Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene manipulation to enhance MIBG-targeted radionuclide therapy.
    Mairs RJ; Fullerton NE; Cosimo E; Boyd M
    Nucl Med Biol; 2005 Oct; 32(7):749-53. PubMed ID: 16243651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry in Peptide radionuclide receptor therapy: a review.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
    Eberle AN; Mild G
    J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo.
    Mairs RJ; Ross SC; McCluskey AG; Boyd M
    J Nucl Med; 2007 Sep; 48(9):1519-26. PubMed ID: 17704246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
    Giblin MF; Veerendra B; Smith CJ
    In Vivo; 2005; 19(1):9-29. PubMed ID: 15796153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-targeting non-viral vector based on polyethylenimine improves gene transfer efficiency.
    Li D; Tang GP; Li JZ; Kong Y; Huang HL; Min LJ; Zhou J; Shen FP; Wang QQ; Yu H
    J Biomater Sci Polym Ed; 2007; 18(5):545-60. PubMed ID: 17550658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to enhance cancer radiotherapy employing gene transfer methods.
    Buchsbaum DJ; Raben D; Stackhouse MA; Khazaeli MB; Rogers BE; Rosenfeld ME; Liu T; Curiel DT
    Gene Ther; 1996 Dec; 3(12):1042-68. PubMed ID: 8986431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoradiotherapy in cancer treatment--basic concepts and future trends.
    Zoller F; Eisenhut M; Haberkorn U; Mier W
    Eur J Pharmacol; 2009 Dec; 625(1-3):55-62. PubMed ID: 19836381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
    Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS
    J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications.
    Bodei L; Paganelli G; Mariani G
    J Nucl Med; 2006 Mar; 47(3):375-7. PubMed ID: 16513604
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
    Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.